Florensis extends assortment with Syngenta Poinsettia
Florensis has obtained the rights from Express Seed to sell and produce Syngentagenetics in Europe per 2023. The acquisition of Syngenta Poinsettia genetics byExpress Seed in America, has made this possible.
- Published on
Wim Mieremet, Corporate Product Manager Cuttings, is very happy with this development.“Sales will start in 2023, among which the key varieties from these genetics like 'Titan', 'Mars', 'Mira' and 'Mirage'. This makes our Poinsettia assortment even more attractive for ourcustomers.The mother stock production will take place at one of our production locations in Ethiopia. Our partner P. van der Haak in The Netherlands becomes responsible for the young plantsproduction.”
Next year Florensis will present the best varieties from Decock Plants, Lazzeri and Syngentabreeding, to offer a complete range to our customers.
